Company
Company

Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.

Always stay updated with the free CMN Newsletter.

Proof Diagnostics

Main (gene editing) focus: CRISPR-based COVID-19 tests

Genome editing tool: CRISPR

Funding stage: Private

Location: Cambridge, MA, USA

Website: https://www.proofdx.com/

Proof Diagnostics is a Massachusetts-based start-up company developing improved CRISPR-based diagnostic tools. The company's technology enables simple, scalable and reliable testing with high sensitivity and time/cost-effectiveness. The company is co-founded by Feng Zhang, who is also the co-founder of Editas Medicine, Sherlock Biosciences, Beam Therapeutics and Arbor Biotechnolgies.

Tags

HashtagProof Diagnostics

Company: Proof Diagnostics
close
Search CRISPR Medicine